Nature Medicine
2, 749 - 751 (1996)
doi:10.1038/nm0796-749
Preventing cervical cancerPatricia BralyDepartment of Obstetrics and Gynecology, Louisiana State University Medical Center, New Orleans, Lousiana, 70112, USA A recent conference reiterates the need for better screening and the development of an HPV vaccine.
REFERENCES
- National Institutes of Health, Consensus Development Conference Statement. Cervical Cancer. April 1−3, 1996.
- Parker, S.L., Tong, T., Bolden, S. & Wingo, P.A. Cancer statistics, 1996. CA — A Cancer J. Clinicians 46, 5−27 (1996). | ChemPort |
- Hayward, R.A. et al. Who gets screened for cervical and breast cancer? Results from a new national survey. Arch. Intern. Med. 148, 1177−1181 (1988). | Article | PubMed | ISI | ChemPort |
- Mandelblatt, J. et al. Gynecological care of elderly women: Another look at Papanicolaou smear testing. JAMA 256, 367−371 (1986). | Article | PubMed | ISI | ChemPort |
- Lehtinen, M. et al Serologically diagnoised infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: Nested case-control study. Br. Med. J. 2, 537−539 (1996).
- Prokopczyk, B. et al. Identification of tobacco-specific carcinogens in the cervical mucus of smokers and nonsmokers. Proc. Am. Assoc. Cancer Res. 37, Abstr. 100 (1996).
- Borysiewicz, L.K. et al. A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet 347, 1523−1527 (1996). | Article | PubMed | ISI | ChemPort |
- Suzich, J.A. et al. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. USA 92, 11553−11557 (1995). | PubMed | ChemPort |
|
